About this entry

Our research team combines expertise in medical microbiology, infectious diseases, molecular biology and biomedical engineering.  For this entry, our team has proposed an innovative approach for the diagnosis of  bacterial  infections in patients suspected to have sepsis. Gram-negative bacteria, particularly Enterobactericeae, and Gram-positive bacteria, such as Staphylococci, are the most common causative pathogens in sepsis. Since bacterial infections are not likely to be differentiated based on the clinical manifestations of patients with sepsis and require different antimicrobial therapies, there is a critical need for point of care diagnosis,  in view of the fact that microbiological cultures are not able to provide rapid results to advise physicians on appropriate antimicrobial therapies. 

If you would like to be introduced to this team for collaboration, get in touch with the Longitude prize.